**Core Concept:**
Transfusion-related acute lung injury (TRALI) is a severe pulmonary complication that occurs in patients receiving blood transfusions. It is a type of acute respiratory distress syndrome (ARDS) caused by the interaction between the recipient's immune system and the transfused plasma. TRALI is characterized by bilateral pulmonary infiltrates, hypoxia, and tachypnea within six hours of plasma transfusion.

**Why the Correct Answer is Right:**
TRALI typically results from the interaction between the recipient's immune system and the transfused plasma, leading to the release of pro-inflammatory cytokines and neutrophils. This process triggers the development of ARDS, which is characterized by bilateral pulmonary infiltrates, hypoxia, and tachypnea. The correct answer (TRALI is not caused by plasma proteins) indicates that plasma proteins themselves are not the primary trigger for TRALI, but rather the immune response between the recipient and the transfused plasma.

**Why Each Wrong Option is Incorrect:**
A. False - Plasma proteins can contribute to TRALI in certain cases, particularly when the plasma is contaminated with neutrophils from the donor.
B. False - Plasma proteins, including antibodies and complement proteins, are essential components of the immune response and contribute to the pathogenesis of TRALI.
C. False - Plasma proteins are not exclusively responsible for TRALI; the immune response between the recipient and the transfused plasma is the primary cause.
D. False - Plasma proteins, despite not causing TRALI directly, can contribute to its development through the activation of the recipient's immune system.

**Clinical Pearl:**
TRALI remains a significant concern in transfusion medicine due to its potential life-threatening complications. Monitoring plasma donors for risk factors (e.g., infections) and implementing appropriate quality control measures can help reduce the incidence of TRALI. In cases where TRALI occurs, the involvement of the recipient's immune system in response to the transfused plasma highlights the importance of considering the patient's individual immune status and potential triggers when managing transfusion reactions.